Cboe Global Markets, Inc. · CBOE · FY2025 Q1 · Calendar Q2 2025
Cboe raises organic revenue outlook on record Q1
The current analysis supports the view that earnings growth and resilient demand can underpin Cboe's business trajectory: record Q1 performance, strong derivatives activity, DataVantage growth, and raised organic revenue guidance are positive evidence. The case remains conditional on sustained volatility and retail participation, successful crypto and Asia-Pacific expansion, disciplined spending, and execution through the CEO transition.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about CBOE FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Versus the prior-quarter analysis, the current analysis shows a stronger operating update: guidance is now raised rather than maintained, crypto products have launched, DataVantage ACV growth is highlighted, and the final equities exchange migration to Titania is complete. The CEO transition to Craig Donahue is a new strategic and execution consideration.
Guidance delta
Management's full-year organic net revenue outlook moved from maintained in the prior analysis to raised, at a mid-to-high single-digit growth range in the current analysis; CapEx remained unchanged at $75-$85 million.
Key takeaways
- The current analysis describes a record Q1, led by derivatives volumes, particularly SPX zero-day and VIX products.
- DataVantage organic growth and higher Asia-Pacific ACV point to added momentum beyond transaction volumes.
- Crypto-product launches, retail education, and the Titania technology migration broaden the growth agenda, while the CEO transition adds an execution item to monitor.
Management priorities
- Expand Asia-Pacific sales and marketing.
- Develop crypto products, including Bitcoin index options and futures.
- Continue Titania platform migration, technology investment, retail education, and product innovation.
- Pursue strategic inorganic opportunities when financially sensible.
Follow CBOE with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Goldman Sachs | Neutral | Sell | Upgrade | Oct 2, 2026 |
| TD Cowen | Hold | Hold | Maintain | Aug 3, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 3, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Jul 28, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 15, 2026 |
| UBS | Neutral | Neutral | Maintain | May 4, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | May 4, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Apr 10, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Nov 3, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 4, 2025 |
| B of A Securities | Neutral | Buy | Downgrade | Apr 10, 2025 |
| Jefferies | Hold | Hold | Maintain | Jan 9, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Nov 11, 2024 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Nov 4, 2024 |
| Rosenblatt | Buy | Buy | Maintain | May 6, 2024 |
| Argus Research | Hold | Buy | Downgrade | Nov 16, 2023 |
| Credit Suisse | Outperform | Neutral | Upgrade | Jan 5, 2023 |
| Compass Point | Buy | Neutral | Upgrade | Oct 7, 2021 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 6, 2020 |
| CFRA | Strong Buy | Buy | Upgrade | Feb 28, 2020 |
| Bank of America | Underperform | Buy | Downgrade | Sep 13, 2019 |
| Raymond James | Market Perform | Outperform | Downgrade | Jun 11, 2019 |
| MKM Partners | Overweight | Neutral | Upgrade | Feb 25, 2019 |
| Evercore ISI Group | Buy | Hold | Upgrade | Oct 10, 2016 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Sep 27, 2016 |
| Buckingham Research | Buy | Neutral | Upgrade | Sep 27, 2016 |
| CLSA | Underperform | Outperform | Downgrade | Feb 8, 2016 |
| Stifel Nicolaus | Market Perform | Market Perform | Maintain | Aug 3, 2015 |
| Stifel | Market Perform | Market Perform | Maintain | Aug 3, 2015 |
| S&P Capital IQ | Strong Buy | Hold | Upgrade | Jan 28, 2014 |
| Macquarie | Outperform | Neutral | Upgrade | Oct 29, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $271.26. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Loop Capital Markets | Analyst unavailable | $300 | $277.19 | +10.6% | Oct 2, 2026 |
| Goldman Sachs | Alexander Blostein | $300 | $277.19 | +10.6% | Oct 2, 2026 |
| Wells Fargo | Analyst unavailable | $301 | $277.19 | +11.0% | Oct 1, 2026 |
| Loop Capital Markets | Eli Abboud | $356 | $289.08 | +31.2% | Aug 5, 2026 |
| Loop Capital Markets | Analyst unavailable | $315 | $299.28 | +16.1% | Aug 3, 2026 |
| Loop Capital Markets | Benjamin Budish | $354 | $310.23 | +30.5% | Aug 3, 2026 |
| Loop Capital Markets | Analyst unavailable | $380 | $310.23 | +40.1% | Aug 3, 2026 |
| Loop Capital Markets | Analyst unavailable | $288 | $288.87 | +6.2% | Jul 28, 2026 |
| Loop Capital Markets | Analyst unavailable | $304 | $274.04 | +12.1% | Jul 20, 2026 |
| Piper Sandler | Patrick Moley | $320 | $274.98 | +18.0% | Jul 15, 2026 |
| Morgan Stanley | Michael Cyprys | $258 | $267.92 | -4.9% | Jul 10, 2026 |
| Loop Capital Markets | Analyst unavailable | $347 | $263.86 | +27.9% | Jul 9, 2026 |
| Loop Capital Markets | Analyst unavailable | $263 | $250.96 | -3.0% | Jun 22, 2026 |
| Redburn Partners | Analyst unavailable | $316 | $301.08 | +16.5% | Jun 11, 2026 |
| Loop Capital Markets | Analyst unavailable | $340 | $339.36 | +25.3% | May 4, 2026 |
| UBS | Analyst unavailable | $335 | $338.76 | +23.5% | May 4, 2026 |
| Loop Capital Markets | Analyst unavailable | $395 | $335.05 | +45.6% | May 4, 2026 |
| Loop Capital Markets | Analyst unavailable | $365 | $337.25 | +34.6% | May 4, 2026 |
| Loop Capital Markets | Analyst unavailable | $335 | $326.96 | +23.5% | May 4, 2026 |
| Loop Capital Markets | Analyst unavailable | $382 | $326.96 | +40.8% | May 4, 2026 |
| Piper Sandler | Analyst unavailable | $321 | $300.75 | +18.3% | Apr 15, 2026 |
| Morgan Stanley | Michael Cyprys | $273 | $294.04 | +0.6% | Apr 10, 2026 |
| Loop Capital Markets | Analyst unavailable | $293 | $294.82 | +8.0% | Apr 9, 2026 |
| RBC Capital | Ashish Sabadra | $303 | $275.82 | +11.7% | Feb 9, 2026 |
| UBS | Alex Kramm | $290 | $275.36 | +6.9% | Feb 9, 2026 |
| Loop Capital Markets | Benjamin Budish | $317 | $273.09 | +16.9% | Feb 9, 2026 |
| Loop Capital Markets | Analyst unavailable | $281 | $262.18 | +3.6% | Jan 14, 2026 |
| Piper Sandler | Patrick Moley | $295 | $266.77 | +8.8% | Jan 14, 2026 |
| Loop Capital Markets | Benjamin Budish | $295 | $255.16 | +8.8% | Jan 8, 2026 |
| UBS | Analyst unavailable | $280 | $255.26 | +3.2% | Jan 7, 2026 |
| Morgan Stanley | Analyst unavailable | $240 | $248.05 | -11.5% | Dec 22, 2025 |
| Loop Capital Markets | Analyst unavailable | $302 | $251.33 | +11.3% | Dec 12, 2025 |
| Loop Capital Markets | Analyst unavailable | $310 | $249.82 | +14.3% | Dec 10, 2025 |
| Loop Capital Markets | Analyst unavailable | $269 | $246.1 | -0.8% | Nov 3, 2025 |
| Loop Capital Markets | Analyst unavailable | $265 | $246.1 | -2.3% | Nov 3, 2025 |
| Piper Sandler | Patrick Moley | $290 | $246.1 | +6.9% | Nov 3, 2025 |
| Loop Capital Markets | Analyst unavailable | $273 | $246.1 | +0.6% | Nov 3, 2025 |
| Loop Capital Markets | Analyst unavailable | $287 | $246.1 | +5.8% | Nov 3, 2025 |
| Piper Sandler | Analyst unavailable | $270 | $243.49 | -0.5% | Oct 14, 2025 |
| Loop Capital Markets | Benjamin Budish | $264 | $240.9 | -2.7% | Oct 8, 2025 |
| Loop Capital Markets | Craig Siegenthaler | $261 | $241.76 | -3.8% | Oct 2, 2025 |
| Morgan Stanley | Analyst unavailable | $221 | $241.96 | -18.5% | Oct 1, 2025 |
| RBC Capital | Analyst unavailable | $254 | $250.87 | -6.4% | Aug 4, 2025 |
| UBS | Analyst unavailable | $255 | $250.87 | -6.0% | Aug 4, 2025 |
| Oppenheimer | Analyst unavailable | $265 | $250.87 | -2.3% | Aug 4, 2025 |
| Piper Sandler | Analyst unavailable | $265 | $250.87 | -2.3% | Aug 4, 2025 |
| Morgan Stanley | Michael Cyprys | $218 | $233.95 | -19.6% | Jul 15, 2025 |
| UBS | Alex Kramm | $245 | $231.67 | -9.7% | May 5, 2025 |
| Loop Capital Markets | Kyle Voigt | $227 | $231.67 | -16.3% | May 5, 2025 |
| Loop Capital Markets | Craig Siegenthaler | $260 | $224.48 | -4.2% | Apr 2, 2025 |
| Barclays | Benjamin Budish | $220 | $203.99 | -18.9% | Dec 9, 2024 |
| Deutsche Bank | Brian Bedell | $222 | $213.23 | -18.2% | Nov 11, 2024 |
| Deutsche Bank | Brian Bedell | $212 | $209.6 | -21.8% | Nov 4, 2024 |
| TD Securities | Bill Katz | $205 | $203.1 | -24.4% | Sep 25, 2024 |
| Morgan Stanley | Michael Cyprys | $188 | $196.27 | -30.7% | Aug 6, 2024 |
| Piper Sandler | Richard Repetto | $210 | $194.06 | -22.6% | Aug 5, 2024 |
| Oppenheimer | Owen Lau | $209 | $193.94 | -23.0% | Aug 5, 2024 |
| Loop Capital Markets | Benjamin Budish | $218 | $193.78 | -19.6% | Aug 5, 2024 |
| Loop Capital Markets | Kenneth Worthington | $195 | $193.78 | -28.1% | Aug 5, 2024 |
| Loop Capital Markets | Craig Siegenthaler | $230 | $193.78 | -15.2% | Aug 4, 2024 |
| Loop Capital Markets | Kenneth Worthington | $166 | $170.22 | -38.8% | Jul 12, 2024 |
| Barclays | Benjamin Budish | $215 | $170.92 | -20.7% | Jul 5, 2024 |
| Rosenblatt Securities | Andrew Bond | $205 | $179.67 | -24.4% | May 6, 2024 |
| Loop Capital Markets | Benjamin Budish | $215 | $179.67 | -20.7% | May 6, 2024 |
| Morgan Stanley | Michael Cyprys | $199 | $182.37 | -26.6% | Apr 9, 2024 |
| Deutsche Bank | Brian Bedell | $178 | $181.57 | -34.4% | Apr 5, 2024 |
| Barclays | Benjamin Budish | $204 | $176.4 | -24.8% | Jan 8, 2024 |
| Piper Sandler | Patrick Moley | $174 | $156.2 | -35.9% | Sep 29, 2023 |
| J.P. Morgan | Analyst unavailable | $125 | $123.56 | -53.9% | Jan 9, 2023 |
| Deutsche Bank | Analyst unavailable | $141 | $122.84 | -48.0% | Nov 15, 2022 |
| Loop Capital Markets | Alexander Blostein | $126 | $117.73 | -53.6% | Sep 30, 2022 |
| Credit Suisse | Analyst unavailable | $145 | $123.38 | -46.5% | Aug 1, 2022 |
| Morgan Stanley | Michael Cyprys | $140 | $118.18 | -48.4% | Jul 19, 2022 |
| Deutsche Bank | Analyst unavailable | $136 | $118.11 | -49.9% | Jul 13, 2022 |
| Credit Suisse | Analyst unavailable | $146 | $120.12 | -46.2% | Jul 13, 2022 |
| Deutsche Bank | Analyst unavailable | $131 | $105.59 | -51.7% | May 19, 2022 |
| UBS | Alex Kramm | $124 | $115.86 | -54.3% | Jul 7, 2021 |
| Barclays | Jeremy Campbell | $97 | $102.77 | -64.2% | Apr 30, 2021 |
Track every rating change on CBOE the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCboe Global Markets, Inc. functions as a global operator of various financial exchanges, primarily renowned for its options trading platforms, all managed through its numerous subsidiaries. The company organizes its expansive business activities into five distinct segments. The Options segment specializes in the trading of listed market indices. Its North American Equities division facilitates transactions for listed stocks in the United States and Canada, also offering services for exchange-traded products (ETPs), encompassing both trading and listing. The Futures segment is dedicated to futures trading.…
Historical context
All CBOE earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.9% | +3.8% | FactSet reports record FY26 results as AI and MCP adoption accelerate |
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the CBOE recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-18T00:01:48.469141+00:00
- Polygon adjusted daily market bars · 2026-10-04T20:50:44.529181+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-04T20:50:44.526291+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-04. For educational purposes only; not investment advice.